NasdaqCM - Delayed Quote • USD
GT Biopharma, Inc. (GTBP)
At close: April 23 at 4:00 PM EDT
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 1 | -- |
| Avg. Estimate | -2.7 | -2.7 | -10.8 | 0 |
| Low Estimate | -2.7 | -2.7 | -10.8 | 0 |
| High Estimate | -2.7 | -2.7 | -10.8 | 0 |
| Year Ago EPS | -0.3 | -1.5 | -5.64 | -10.8 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 1 | 1 |
| Avg. Estimate | -- | -- | -- | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | -- | -- | -- | -- |
Earnings History
| CURRENCY IN USD | 3/31/2023 | 6/30/2023 | 9/30/2023 | 12/31/2023 |
|---|---|---|---|---|
| EPS Est. | -4.35 | -3 | -3 | -2.7 |
| EPS Actual | -0.3 | -1.5 | -1.8 | -2.19 |
| Difference | 4.05 | 1.5 | 1.2 | 0.51 |
| Surprise % | 93.10% | 50.00% | 40.00% | 18.90% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | -2.7 | -2.7 | -10.8 | 0 |
| 7 Days Ago | -2.7 | -2.7 | -10.8 | -0.64 |
| 30 Days Ago | -2.7 | -2.7 | -10.8 | -0.64 |
| 60 Days Ago | -2.7 | -2.7 | -10.8 | -0.64 |
| 90 Days Ago | -0.09 | -0.09 | -0.36 | -0.64 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | 1 |
| Up Last 30 Days | -- | -- | -- | 1 |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | GTBP | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | -800.00% | -- | -- | 1.50% |
| Next Qtr. | -80.00% | -- | -- | 11.40% |
| Current Year | -91.50% | -- | -- | 5.20% |
| Next Year | -- | -- | -- | 13.40% |
| Next 5 Years (per annum) | -- | -- | -- | 11.09% |
| Past 5 Years (per annum) | -- | -- | -- | -- |
Research Analysis
Related Tickers
XBIOW Xenetic Biosciences, Inc.
7.46
-17.11%
SRZN Surrozen, Inc.
8.97
-1.75%
CDT Conduit Pharmaceuticals Inc.
3.1800
+0.95%
OBIO Orchestra BioMed Holdings, Inc.
4.4800
-0.88%
AKTX Akari Therapeutics, Plc
1.1900
-2.46%
EVLO Evelo Biosciences, Inc.
0.0442
+4.00%
EDSA Edesa Biotech, Inc.
4.3100
-2.93%
34LA.F Alpine Immune Sciences, Inc.
59.00
-0.84%
I9DN.F Arbutus Biopharma Corporation
2.5020
-0.56%
SRZNW Surrozen, Inc.
0.0221
0.00%